Form 8-K - Current report:
SEC Accession No. 0001493152-23-024401
Filing Date
2023-07-13
Accepted
2023-07-13 09:15:33
Documents
25
Period of Report
2023-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43821
2 ex10-1.htm EX-10.1 161620
3 ex10-2.htm EX-10.2 6198
4 ex10-3.htm EX-10.3 74845
5 ex10-4.htm EX-10.4 93046
6 ex10-5.htm EX-10.5 110105
7 ex10-1_001.jpg GRAPHIC 1073
8 ex10-2_001.jpg GRAPHIC 331167
9 ex10-2_002.jpg GRAPHIC 428111
10 ex10-2_003.jpg GRAPHIC 422913
11 ex10-2_004.jpg GRAPHIC 366551
12 ex10-2_005.jpg GRAPHIC 470171
13 ex10-2_006.jpg GRAPHIC 402238
14 ex10-2_007.jpg GRAPHIC 103978
  Complete submission text file 0001493152-23-024401.txt   4234154

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE otlc-20230707.xsd EX-101.SCH 3018
16 XBRL LABEL FILE otlc-20230707_lab.xml EX-101.LAB 34240
17 XBRL PRESENTATION FILE otlc-20230707_pre.xml EX-101.PRE 22361
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3037
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 231085854
SIC: 2834 Pharmaceutical Preparations